Intravascular Radiofrequency Ablation of Sympathetic Nerves for the Treatment of Hepatocellular Carcinoma

Patients who met the inclusion criteria were treated with endovascular radiofrequency ablation and desympathetic nerve surgery. After enrollment, endovascular radiofrequency ablation and desympathetic surgery were performed. After radiofrequency ablation, the safety and efficacy of follow-up treatment will be carried out every 1 month or so, including blood routine, liver and kidney function, tumor indicators, abdominal CT/magnetic resonance, etc.

Trial Details

NCT ID
NCT06694636
Phase
NA
Sponsor
Zhongda Hospital
Status
RECRUITING
Cancer Type
Liver Cancer
Interventions
  • endovascular radiofrequency ablation and desympathetic nerve surgery
Locations (sample)
  • Nanjing, Jiangsu, China|32.06167,118.77778

Key Eligibility Criteria

  • Clinically or pathologically confirmed hepatocellular carcinoma (HCC)
  • Locally progressed or distant metastatic unresectable advanced HCC
  • Progressed after second-line therapy
  • Agree to participate in the study and sign the informed consent form

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Liver Cancer Trials on Trialify →